BioSpace News Archive

United Neuroscience (UNS) announced positive top-line results from its Phase 2a clinical study of UB-311, a novel synthetic peptide vaccine targeting beta amyloid (Aβ) in the treatment of Alzheimer’s disease

Austin-based CSA Acquires Wilmington, Ohio-based EMSAR

Reports from the World Health Organization indicate global alcohol use is on the rise with 3.3 million annual deaths around the world are attributed to alcohol consumption.

First 100 orders receive a 15% discount

Simione Healthcare Consultants Drives Results in Home Care & Hospice

United Spinal Association is pleased to announce the appointment of Danielle Corazza, an experienced military and veteran advocate, as the new vice president of its VetsFirst program, which supports veterans with disabilities in achieving the highest level of independence and quality of life.

Cannabis has become the new craze as legalization efforts continue to spread. The cannabis movement has gone into full swing, with recent milestones like Canada’s complete legalization of cannabis and the U.S. adding an additional three states to its growing list of pro-cannabis states.

NEXT VENTURES™, a recently launched venture capital firm designed to maximize growth opportunities in the exploding sports, fitness, nutrition and wellness markets, today announced a significant lead investment in PowerDot, the world’s first app-based, smart muscle stimulation device, designed to provide increased wellness, recovery and performance enhancement.

Top Private Equity Investor Fuels Human Performance Company to Elevate Organizations and Their Employees to Be Great at Anything

Due to the positive results from the first two phases of testing where the AAGP® treated cells showed a dramatic increase in survivability versus untreated cells over a four-week period, we are now expanding the study.